We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Imaging Significantly Underestimates the Size of DCIS Tumors

By MedImaging International staff writers
Posted on 15 Apr 2021
Print article
Image: Imaging can underestimate the actual size of a breast tumor (Photo courtesy of Getty Images)
Image: Imaging can underestimate the actual size of a breast tumor (Photo courtesy of Getty Images)
A new study suggests that pre-operative imaging of high-volume ductal carcinoma in situ (DCIS) lesion size is inaccurate.

Researchers at the University of British Columbia (UBC; Vancouver, Canada), Western University (UWO; London, Canada), and Mount Saint Joseph Hospital (Vancouver, Canada) undertook a retrospective review of clinicopathologic data of patients treated for DCIS with breast conserving surgery (BCS) between 2012 and 2018. Mammographic and sonographic lesion sizes were compared with final pathology sizes.

The results showed that for 152 lesions visible on mammography, mean size on imaging was significantly smaller when compared to final pathology (2.3 centimeters versus 3.6 centimeters, respectively); the mean difference of 1.3 cm was a significant underestimation, with a correlation coefficient of 0.367. For the 48 lesions visible on ultrasound, the radiologic size was significantly smaller than pathologic size (1.7 centimeters versus 4.1 centimeters, respectively), but degree of underestimation was not significantly correlated. The study was published on March 23, 2021, in The American Journal of Surgery.

“Imaging size of DCIS tumors assessed by both mammography and ultrasound were significantly smaller when compared with their final size on pathology,” concluded lead author Rachel Liu, MD, of UWO, and colleagues. “Increase in the degree of underestimation by mammography was noted as the histological tumor size increased. This must be taken into consideration during surgical planning for maximizing the success of breast conserving surgery and minimizing return to the operating room.”

DCIS is the most common type of non-invasive breast cancer, in which the abnormal cells are contained inside the milk ducts. If DCIS is not treated, it may eventually develop into invasive breast cancer, which can spread outside the ducts into the breast tissue and then possibly to other parts of the body. Since DCIS cannot usually be felt as a breast lump or other breast change, most cases are diagnosed following routine screening with mammograms or ultrasound, appearing as micro-calcifications.

Related Links:
University of British Columbia
Western University
Mount Saint Joseph Hospital


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Portable Radiology System
DRAGON ELITE & CLASSIC
Mammography System
MAMMOVISTA B.smart

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.